- Home
- GMGI vs MIST Comparison
GMGI vs MIST Comparison
Compare GMGI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- MIST
- Stock Information
- Founded
- GMGI 2008
- MIST 2003
- Country
- GMGI United States
- MIST Canada
- Employees
- GMGI N/A
- MIST N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- MIST Health Care
- Exchange
- GMGI Nasdaq
- MIST Nasdaq
- Market Cap
- GMGI 145.9M
- MIST 164.9M
- IPO Year
- GMGI N/A
- MIST N/A
- Fundamental
- Price
- GMGI $1.01
- MIST $1.83
- Analyst Decision
- GMGI Strong Buy
- MIST Strong Buy
- Analyst Count
- GMGI 1
- MIST 3
- Target Price
- GMGI $4.00
- MIST $6.33
- AVG Volume (30 Days)
- GMGI 209.6K
- MIST 1.5M
- Earning Date
- GMGI 11-12-2025
- MIST 11-11-2025
- Dividend Yield
- GMGI N/A
- MIST N/A
- EPS Growth
- GMGI N/A
- MIST N/A
- EPS
- GMGI N/A
- MIST N/A
- Revenue
- GMGI $172,818,124.00
- MIST N/A
- Revenue This Year
- GMGI $25.28
- MIST N/A
- Revenue Next Year
- GMGI $14.90
- MIST N/A
- P/E Ratio
- GMGI N/A
- MIST N/A
- Revenue Growth
- GMGI 54.66
- MIST N/A
- 52 Week Low
- GMGI $0.91
- MIST $0.63
- 52 Week High
- GMGI $3.06
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- GMGI 43.39
- MIST 46.50
- Support Level
- GMGI $0.98
- MIST $1.85
- Resistance Level
- GMGI $1.16
- MIST $1.95
- Average True Range (ATR)
- GMGI 0.06
- MIST 0.10
- MACD
- GMGI 0.01
- MIST -0.02
- Stochastic Oscillator
- GMGI 25.62
- MIST 19.66
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).